Europe — EMA
Neostigmin Sad (Neostigmine Bromide)
GNH USA supplies Neostigmin Sad (Neostigmine), a acetylcholinesterase inhibitor for myasthenia gravis, reversal of neuromuscular blockade and postoperative
Request sourcing
What is Neostigmine Bromide?
Neostigmine, the active ingredient in Neostigmin Sad, is an acetylcholinesterase inhibitor presented as a sterile solution for injection for intramuscular, intravenous, and subcutaneous use. It is employed in the management of myasthenia gravis, reversal of neuromuscular blockade, and postoperative ileus.
GNH USA supplies Neostigmin Sad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Neostigmine Bromide used for?
Neostigmine acts on the cholinergic neuromuscular pathway and is used for several well‑established clinical indications.
Myasthenia gravis: improves skeletal muscle strength by enhancing neuromuscular transmission. Reversal of neuromuscular blockade: restores spontaneous respiration after surgery. Postoperative ileus: stimulates gastrointestinal motility to promote bowel recovery.
What are the side effects of Neostigmine Bromide?
Neostigmine may cause a range of adverse reactions, from mild to severe.
Common Side Effects: - Nausea or vomiting - Increased salivation or sweating - Abdominal cramps or diarrhea - Muscle fasciculations
Serious or Rare Side Effects: - Bradycardia or severe hypotension - Bronchospasm or respiratory distress - Cholinergic crisis with muscle weakness - Seizures or convulsions
What precautions apply to Neostigmine Bromide?
Neostigmine requires careful monitoring in several clinical situations.
Renal impairment: adjust dose because the drug is renally excreted. History of asthma or COPD: monitor for bronchospasm. Concurrent anticholinergic therapy: avoid antagonistic effects. Known hypersensitivity: discontinue immediately if reaction occurs. Store at room temperature: keep in original container, protect from moisture and light.
What does Neostigmine Bromide interact with?
Neostigmine can interact with other medications, altering its efficacy or safety.
Major Interactions (Avoid): - Succinylcholine: potentiates neuromuscular blockade. - Beta‑blockers: may exacerbate bradycardia. - Anticholinergic agents: reduce therapeutic effect.
Moderate Interactions (Monitor Closely): - Volatile anesthetics: may enhance cholinergic response. - Aminoglycoside antibiotics: increase risk of neuromuscular weakness. - Loop diuretics: may worsen electrolyte disturbances.


